We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.58B
AUM Growth
+$210M
Cap. Flow
+$71.1M
Cap. Flow %
4.5%
Top 10 Hldgs %
18.14%
Holding
221
New
32
Increased
92
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$12.6M
2
PIII icon
P3 Health Partners
PIII
+$10.1M
3
MRVI icon
Maravai LifeSciences
MRVI
+$9.23M
4
NARI
Inari Medical, Inc. Common Stock
NARI
+$8.99M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$8.85M

Top Sells

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$13M
2
DMTK
DermTech, Inc. Common Stock
DMTK
+$12.9M
3
OSH
Oak Street Health, Inc.
OSH
+$11.8M
4
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$9.93M
5
DNA icon
Ginkgo Bioworks
DNA
+$8.89M

Sector Composition

Rank Sector Weight
1 Healthcare 30.22%
2 Technology 18.11%
3 Financials 10.26%
4 Industrials 8.95%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAC icon
151
Marriott Vacations Worldwide
VAC
$4.25B
$884K 0.06%
+5,231
New +$841K
ODFL icon
152
Old Dominion Freight Line
ODFL
$44.9B
$864K 0.05%
4,822
– –
MAC icon
153
Macerich
MAC
$6.92B
$816K 0.05%
47,244
-84,708
-64% -$1.59M
ULTA icon
154
Ulta Beauty
ULTA
$24.3B
$811K 0.05%
1,967
– –
JBHT icon
155
JB Hunt Transport Services
JBHT
$25.2B
$757K 0.05%
3,702
– –
DAR icon
156
Darling Ingredients
DAR
$9.44B
$670K 0.04%
9,670
-12,247
-56% -$890K
TER icon
157
Teradyne
TER
$59.3B
$655K 0.04%
4,004
+849
+27% +$119K
MCHP icon
158
Microchip Technology
MCHP
$46B
$631K 0.04%
7,244
– –
TRMB icon
159
Trimble
TRMB
$13.9B
$596K 0.04%
6,831
– –
BURL icon
160
Burlington
BURL
$23.2B
$520K 0.03%
1,784
-206
-10% -$57.9K
XBI icon
161
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$493K 0.03%
4,407
-26,840
-86% -$3.24M
BAH icon
162
Booz Allen Hamilton
BAH
$9.15B
$474K 0.03%
+5,594
New +$472K
LPLA icon
163
LPL Financial
LPLA
$28.6B
$438K 0.03%
2,738
– –
PTLO icon
164
Portillo's
PTLO
$321M
$271K 0.02%
+7,213
New +$289K
COUP
165
DELISTED
Coupa Software Incorporated
COUP
$209K 0.01%
1,320
-10,981
-89% -$2.26M
SLGCW
166
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$91K 0.01%
27,148
– –
ADI icon
167
Analog Devices
ADI
$190B
– –
-4,621
Closed -$774K
ALXO icon
168
ALX Oncology
ALXO
$290M
– –
-47,872
Closed -$3.54M
BYRN icon
169
Byrna Technologies
BYRN
$101M
– –
-96,269
Closed -$2.1M
CHGG icon
170
Chegg
CHGG
$102M
– –
-102,203
Closed -$6.95M
CSGP icon
171
CoStar Group
CSGP
$12.3B
– –
-45,483
Closed -$3.91M
DOCU
172
DocuSign
DOCU
$11.5B
– –
-3,484
Closed -$897K
DOW icon
173
Dow Inc
DOW
$21.2B
– –
-110,000
Closed -$6.33M
HOWL icon
174
Werewolf Therapeutics
HOWL
$19.3M
– –
-296,283
Closed -$5.08M
JOBY icon
175
Joby Aviation
JOBY
$8.55B
– –
-148,591
Closed -$1.5M
4 5 6
7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Nicholas Investment Partners held 221 positions worth $1.58B, up 15% from $1.37B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners deployed $71.1M of net new capital in Q4 2021, opening 32 new positions and adding to 92 existing holdings. Its largest new stake was P3 Health Partners: 21,075 shares worth $7.42M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ginkgo Bioworks, an estimated $8.89M trimmed.

  • Nicholas Investment Partners's largest Q4 2021 buy was P3 Health Partners: 21,075 shares worth $7.42M.
  • Nicholas Investment Partners added most to Ascendis Pharma A/S in Q4 2021, an estimated $12.6M increase.
  • Nicholas Investment Partners's biggest Q4 2021 reduction was Ginkgo Bioworks, cutting an estimated $8.89M.
  • Nicholas Investment Partners fully exited Amyris Inc. in Q4 2021, selling an estimated $13M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.58B portfolio in Q4 2021.
  • Nicholas Investment Partners opened 32 new positions and closed 27 in Q4 2021.
  • Nicholas Investment Partners's portfolio value rose 15% quarter-over-quarter to $1.58B.

Based on Nicholas Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.